Daniel Ek believes prevention is the key to a long life. He’s bringing a ‘new healthcare experience’ to NYC for the first time

Neko Health is taking its body-scanning technology to America.

The Swedish diagnostic health clinic, cofounded by Hjalmar Nilsonne and Daniel Ek (also the cofounder and CEO of Spotify), said on Wednesday that it will launch a location in New York City, its first in the United States, in the spring of this year.

The three-year-old startup, which offers comprehensive body scans to monitor risk factors for a range of health conditions from pre-diabetes to cancer, already has a presence in London, Manchester, and Stockholm.

“For the first time, technology is enabling a fundamentally new healthcare experience centered on prevention,” Nilsonne, who is the company’s CEO, said in a statement. “We’re excited to bring our unique model of care to the world’s biggest healthcare market with the opening of our first US location in Spring this year.”

The exact site of the planned New York City location has not been revealed.

The announcement comes as Neko Health has seen surging demand for its “Body Scan” service, which the company describes as “a preventative health check for your future self.”

Scans check for skin irregularities, gauge the health of your cardiovascular system, assess blood sugar and cholesterol levels, and more as a part of a 60-minute assessment.

Neko Health says its scans use “proprietary sensors, 3D imaging, and blood analysis,” and “results are delivered on-site within minutes, followed by a consultation with a medical professional to discuss personalized health findings.”

Poised for growth

The idea has caught on, according to Neko Health, which says it delivered “six times more scans in 2025 than in 2024, with global signups now exceeding 300,000 people.”

The firm’s data also shows that of the thousands of scans it completed in Stockholm during 2024, 1.2% revealed life-threatening conditions, and 6.4% found “medically significant findings requiring clinical attention.”

Neko Health’s services have caught the attention of the media, and have been reviewed by writers and reporters for publications such as Harper’s Bazaar, Cosmopolitan, and GQ, among others, with generally positive takeaways.

It’s also caught the attention of investors. A year ago, the company announced that it had raised $260 million as part of a Series B funding round. That put the company’s valuation at $1.8 billion.